Cargando…
Innovation in Informatics to Improve Clinical Care and Drug Accessibility for Rare Diseases in China
Background: In China, there are severe unmet medical needs of people living with rare diseases. Relatedly, there is a dearth of data to inform rare diseases policy. This is historically partially due to the lack of informatics infrastructure, including standards and terminology, data sharing mechani...
Autores principales: | Liu, Peng, Gong, Mengchun, Li, Jie, Baynam, Gareth, Zhu, Weiguo, Zhu, Yicheng, Chen, Limeng, Gu, Weihong, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553959/ https://www.ncbi.nlm.nih.gov/pubmed/34721018 http://dx.doi.org/10.3389/fphar.2021.719415 |
Ejemplares similares
-
National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses
por: Guo, Jian, et al.
Publicado: (2021) -
Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
por: Pauwels, Kim, et al.
Publicado: (2016) -
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries
por: Gozzo, Lucia, et al.
Publicado: (2022) -
Valorising and Creating Access to Innovative Medicines in the European Union
por: Annemans, Lieven, et al.
Publicado: (2011) -
Innovation in health informatics
por: Lytras, Mltiadis D, et al.
Publicado: (2019)